REAL-WORLD IMPACT OF MINIMAL RESIDUAL DISEASE ASSESSMENT IN PATIENTS TREATED WITH VENETOCLAX CONTAINING REGIMENS WITH RELAPSED/REFRACTORY CLL СтатьяAkhmetova Alina, Kisiova Maria, Dmitrieva Elena, Naumova Elena, Pochtar Margarita, Lugovskaya Svetlana, Kobzev Yury, Biderman Bella, Likold Ekaterina, Sudarikov Andrey, Stuklov Nikolai, Ptushkin Vadim, Nikitin EugeneКлиническая онкогематология. Фундаментальные исследования и клиническая практика. Том 18. 2025. С. 80-83
